Health Kick: Cynata’s stem cell therapy could be a game changer for COVID-19 patients
Health & Biotech
share
Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast.
In this episode Tim chats with Dr Ross Macdonald, CEO of Cynata Therapeutics (ASX:CYP).
Cynata is an Australian stem cell and regenerative medicine company developing a therapeutic stem cell platform technology, Cymerus™, using discoveries made at the University of Wisconsin-Madison.
The company grabbed headlines earlier in 2o2o with news that it was conducting clinical trials into the efficacy of its stem cell therapy for the treatment of COVID-19 patients.
So click below to hear the pair discuss the company’s origins, COVID-19 and Cynata’s year ahead.
On mobile? Click here to listen with Apple podcasts, here for Spotify or here for Google Podcasts.
Like to listen to podcasts through another app? Just search for The Health Kick Podcast with Tim Boreham and subscribe!
